S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
CVE:KNE

Kane Biotech Inc. (KNE.V) Stock Forecast, Price & News

C$0.14
+0.01 (+3.57 %)
(As of 01/15/2021 09:30 AM ET)
Add
Compare
Today's Range
C$0.15
Now: C$0.15
C$0.15
50-Day Range
C$0.00
MA: C$0.14
C$0.16
52-Week Range
C$0.09
Now: C$0.15
C$0.26
Volume40,180 shs
Average Volume41,537 shs
Market CapitalizationC$15.75 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms in Canada and internationally. It develops pet oral care solutions under the StrixNB and bluestem trademarks; animal and human wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; and shampoos for dogs, cats, and horses under the Alosera trademark. The company was founded in 2001 and is based in Winnipeg, Canada.

MarketRank

Overall MarketRank

0.42 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-204-4531301
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.65 million
Cash FlowC$0.01 per share
Book ValueC($0.01) per share

Profitability

Miscellaneous

Market CapC$15.75 million
Next Earnings Date4/1/2021 (Estimated)
OptionableNot Optionable
C$0.14
+0.01 (+3.57 %)
(As of 01/15/2021 09:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KNE News and Ratings via Email

Sign-up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Kane Biotech Inc. (KNE.V) (CVE:KNE) Frequently Asked Questions

How has Kane Biotech Inc. (KNE.V)'s stock been impacted by Coronavirus?

Kane Biotech Inc. (KNE.V)'s stock was trading at C$0.18 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KNE stock has decreased by 19.4% and is now trading at C$0.15.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Kane Biotech Inc. (KNE.V)?

Wall Street analysts have given Kane Biotech Inc. (KNE.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Kane Biotech Inc. (KNE.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Kane Biotech Inc. (KNE.V)'s next earnings date?

Kane Biotech Inc. (KNE.V) is scheduled to release its next quarterly earnings announcement on Thursday, April 1st 2021.
View our earnings forecast for Kane Biotech Inc. (KNE.V)
.

How were Kane Biotech Inc. (KNE.V)'s earnings last quarter?

Kane Biotech Inc. (KNE.V) (CVE:KNE) issued its quarterly earnings results on Thursday, November, 26th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.36 million for the quarter.
View Kane Biotech Inc. (KNE.V)'s earnings history
.

Who are some of Kane Biotech Inc. (KNE.V)'s key competitors?

Who are Kane Biotech Inc. (KNE.V)'s key executives?

Kane Biotech Inc. (KNE.V)'s management team includes the following people:
  • Mr. Marc Edwards, Pres, CEO & Director
  • Mr. Ray Dupuis, Chief Financial Officer
  • Dr. Gordon Guay, Chief Scientific Officer & Member of Scientific Advisory Board
  • Ms. Lori Christofalos, Director of Quality & Compliance
  • Dr. Jean Gauvin, Chief Veterinary Officer & Member of Scientific Advisory Board
  • Mr. Kevin Cole, Pres & CEO of STEM Animal Health Inc
  • Mr. Mark Ahrens-Townsend, Advisor

What is Kane Biotech Inc. (KNE.V)'s stock symbol?

Kane Biotech Inc. (KNE.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KNE."

How do I buy shares of Kane Biotech Inc. (KNE.V)?

Shares of KNE and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Kane Biotech Inc. (KNE.V)'s stock price today?

One share of KNE stock can currently be purchased for approximately C$0.15.

How big of a company is Kane Biotech Inc. (KNE.V)?

Kane Biotech Inc. (KNE.V) has a market capitalization of C$15.75 million and generates C$1.65 million in revenue each year.

What is Kane Biotech Inc. (KNE.V)'s official website?

The official website for Kane Biotech Inc. (KNE.V) is www.kanebiotech.com.

How can I contact Kane Biotech Inc. (KNE.V)?

Kane Biotech Inc. (KNE.V)'s mailing address is 162-196 Innovation Dr, WINNIPEG, MB R3T 6C5, Canada. The company can be reached via phone at +1-204-4531301.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.